Legal Troubles Beset Pharmaceutical Sector ETFs

This article was originally published on ETFTrends.com.

Pharmaceutical ETFs may be in trouble with legal troubles looming over the industry. The drugmaker segment recently sold-off after an amended civil antitrust complaint brought by more than 40 state attorneys general alleged that 15 individuals and 20 corporate defendants conspired to fix prices on over 100 generic drugs, the Wall Street Journal reports. Teva […]

Continue Reading Below

Read more at ETFTrends.com >

Free America Network Articles

Leave a Comment